Study finds lower dose of malaria drug may block transmission

11/18/2013 | Medical News Today

Lower doses of the malaria drug primaquine were found to work as well as the standard dose, according to a study in The Lancet Infectious Diseases. Researchers said the lower dose might prevent cases of reduced blood count, a side effect in patients with G6PD enzyme deficiency.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC